TY - JOUR
T1 - Hemorheological, hemostatic and metabolic long-term (24 months) study of young women taking a monophasic pill containing gestodene and ethinylestradiol
AU - Solerte, S. B.
AU - Fioravanti, M.
AU - Spinillo, A.
AU - Capuzzo, E.
AU - Iasci, A.
AU - Mastrolilli, M.
AU - Berard, P.
AU - Reboli, P.
AU - Ferrari, E.
AU - Guaschino, S.
PY - 1993
Y1 - 1993
N2 - Objective: To investigate the hemoreologic, hemostatic and metabolic effects of a monophasic low-dose oral contraceptive. Methods: Twenty healthy young women desiring hormonal contraception were studied before, during and after a 2 year course of a monophasic oral contraceptive containing gestodene 75 μg and ethinylestradiol 30 μg. Twenty-nine matched healthy young women were chosen as the control group. Results: No differences in any of the variables evaluated (body mass index, blood pressure, erythrocyte deformability, concentrations of triglycerides, total HDL, LDL and VLDL cholesterol, non-esterified fatty acids, serum lipoproteins VLDL, LDL, HDL and apolipoproteins A, A1 and B, fibrinogen, fibronectin, von Willebrand factor antigen, α2-macroglobulin, antithrombin III, prolactin) were demonstrated between the women taking the monophasic pill and the control group. Conclusion: Oral contraception with the monophasic gestodene and ethinylestradiol combination may be a safe long-term hormonal contraceptive method for young women and prevent the development of cardiovascular complications.
AB - Objective: To investigate the hemoreologic, hemostatic and metabolic effects of a monophasic low-dose oral contraceptive. Methods: Twenty healthy young women desiring hormonal contraception were studied before, during and after a 2 year course of a monophasic oral contraceptive containing gestodene 75 μg and ethinylestradiol 30 μg. Twenty-nine matched healthy young women were chosen as the control group. Results: No differences in any of the variables evaluated (body mass index, blood pressure, erythrocyte deformability, concentrations of triglycerides, total HDL, LDL and VLDL cholesterol, non-esterified fatty acids, serum lipoproteins VLDL, LDL, HDL and apolipoproteins A, A1 and B, fibrinogen, fibronectin, von Willebrand factor antigen, α2-macroglobulin, antithrombin III, prolactin) were demonstrated between the women taking the monophasic pill and the control group. Conclusion: Oral contraception with the monophasic gestodene and ethinylestradiol combination may be a safe long-term hormonal contraceptive method for young women and prevent the development of cardiovascular complications.
UR - http://www.scopus.com/inward/record.url?scp=0027521650&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0027521650&partnerID=8YFLogxK
M3 - Article
AN - SCOPUS:0027521650
VL - 5
SP - 85
EP - 91
JO - Italian Journal of Gynaecology and Obstetrics
JF - Italian Journal of Gynaecology and Obstetrics
SN - 1121-8339
IS - 3
ER -